ROS1-rearranged NSCLC With Secondary Resistance Mutation: Case Report and Current Perspectives

Florian Guisier(Inserm), Luc Thiberville(Inserm)

Clinical Lung Cancer

June 13, 2019

10.1016/j.cllc.2019.06.007

Cited by 18

Related Papers

ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date

|Current Oncology|2022|118

In- and ex-vivo molecular imaging of apoptosis to assess sensitivity of non-small cell lung cancer to EGFR inhibitors using probe-based confocal laser endomicroscopy

|PLoS ONE|2017|9

Correlation of programmed death-ligand 1 expression in tumour cells between diagnostic small biopsies performed by radial EBUS and surgical specimens of peripheral lung cancer

|BMJ Open Respiratory Research|2024|3